TNFRSF9 and Autoimmunity: Patients having reduced or ablated expression of CD137 show hampered immune regulation, being susceptible to various pathogens including Epstein-Barr virus (EBV) and predisposed to EBV-related B-cell lymphoma as well as showing symptoms of autoimmunity (21, 22).